Martin M., Ruiz A, Muñoz M., Balil A., Garcia-Mata J., Calvo L., Carrasco E., Mahillo E., Casado A., Garcia-Sáenz JA., Escudero MJ., Guillem V., Jara C., Ribelles N, Salas F., Soto C., Morales-Vásquez F., Rodríguez CA., Adrover E., Mel JR.; Spanish Breast Cancer Research Group (GEICAM) trial. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. Lancet Oncology 2007; 8(3):219-25.
Para más información vaya al siguiente enlace:
http://www.ncbi.nlm.nih.gov/pubmed/17329192